Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients
Journal of Investigational Allergy and Clinical Immunology · 2025
DOI: 10.18176/jiaci.0968 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Investigational Allergy and Clinical Immunology, 2025. Verfasst von D Calzada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unidad I+D, LETI Pharma. S.L.U., Madrid, Spain. Hauptthemen laut MEDLINE: Antigens, Dermatophagoides, Dermatophagoides pteronyssinus, Hypersensitivity, Asthma. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Objective
To analyze sensitization to Dermatophagoides pteronyssinus and to investigate the association between diagnostic findings and clinical severity in 218 allergic patients from 2 continents.
Methods
Mite-allergic patients were recruited by allergology departments in Latin America (n=88: Colombia, Costa Rica, and Guatemala) and Spain (n=130). All patients had allergic rhinitis with or without asthma and positive skin prick test results to D pteronyssinus. Specific IgE levels to D pteronyssinus, Dermatophagoides farinae, Der p 1, Der p 2, and Der p 23 were quantified using ImmunoCAP (Thermo Fisher Scientific). The allergenic profile was also determined by Western blotting. A comparative statistical analysis was performed using GraphPad software.
Results
Patients most frequently recognized Der p 2 (79%), followed by Der p 1 (73%) and Der p 23 (69%). The percentage of patients with asthma increased with the number of sensitizations; however, no statistically significant differences were found. Interestingly, patients with asthma presented the highest median levels of total IgE and specific IgE for D pteronyssinus and molecular allergens, mainly Der p 2. Analysis of both populations revealed that Spanish patients were predominantly sensitized to Der p 2 (88.46%) and Der p 1 (83.84%), whereas Latin American patients were more sensitized to Der p 23.
Conclusions
Our data support the relevance of Der p 2 as the major allergen in mite allergy. A large percentage of patients are sensitized to this allergen, which plays a key role in the development of asthma. Sensitization to Der p 23 was more relevant in Latin America.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad I+D, LETI Pharma. S.L.U., Madrid, Spain.
- Servicio de Alergología, Hospital Clínic, IDIBAPS Barcelona, RICORS, Spain.
- Unidad de Alergia, Fundación Valle del Lili, Cali, Colombia.
- Centro Diagnóstico y Tratamiento de Alergia, San José, Costa Rica.
- Universidad Rafael Landívar, Facultad de Medicina, Cátedra de Inmunología, Guatemala City, Guatemala.
- Servicio de Inmunología, CDB, Hospital Clínic, IDIBAPS Barcelona, RICORS, Barcelona, Spain.
Zitieren
APA
Calzada, D., Bartra, J., Serrano, C. D., Riggioni, S., Moran, E., Maselli, J. P., Silva, D. L., Ramirez, L. F., Pascal, M., Carnés, J., & Valero, A. (2025). Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients. Journal of Investigational Allergy and Clinical Immunology. https://doi.org/10.18176/jiaci.0968
Vancouver
Calzada D, Bartra J, Serrano CD, Riggioni S, Moran E, Maselli JP, et al. Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients. Journal of Investigational Allergy and Clinical Immunology. 2025. doi:10.18176/jiaci.0968
BibTeX
@article{Calzada2025,
author = {Calzada, D and Bartra, J and Serrano, C D and Riggioni, S and Moran, E and Maselli, J P and Silva, D L and Ramirez, L F and Pascal, M and Carnés, J and Valero, A},
title = {Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients},
journal = {Journal of Investigational Allergy and Clinical Immunology},
year = {2025},
doi = {10.18176/jiaci.0968}
}
EUVIMED